Renovaro BiosciencesRENB 
$0.53-2.96%24h
-2.96%24h
Global rank27151
Market cap$29.54M
Change 7d-16.67%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.74
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Renovaro Biosciences (RENB)
As of November 2024, Renovaro Biosciences has a market cap of $29.54M. This makes Renovaro Biosciences the world's 27151th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Renovaro Biosciences from 2018 to 2024
-
Value:-
Market cap history of Renovaro Biosciences from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $114.22M | -35.96% |
| 2023 | $178.36M | 207.77% |
| 2022 | $57.95M | -85.87% |
| 2021 | $410.17M | 147.12% |
| 2020 | $165.98M | -41.24% |
| 2019 | $282.45M | -28.29% |
| 2018 | $393.86M | - |
RENB Market Cap Today is $29.54M -2.96% - 15 Nov 2024
View largest stocks by market cap 
